Greenberg Traurig, LLP represented Hangzhou Zhongmei Huadong Pharmaceutical and Huadong Medicine Co. on the matter. Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused...
Hangzhou Zhongmei Huadong Pharmaceutical Co..’s Licensing Agreement with Arcutis Biotherapeutic
Hangzhou Zhongmei Huadong Pharmaceutical’s Licensing Agreement with MC2 Therapeutics
Greenberg Traurig, LLP represented Hangzhou Zhongmei Huadong Pharmaceutical and Huadong Medicine Co. on the matter. Hangzhou Zhongmei Huadong Pharmaceutical, a subsidiary of Huadong Medicine, negotiated a licensing agreement...
Huadong Medicine’s Collaboration with Kiniksa Pharmaceuticals
Greenberg Traurig represented Huadong Medicine on the deal, while Ropes & Gray advised Kiniksa Pharmaceuticals. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a wholly owned subsidiary of...
Huadong’s Strategic Partnership With Heidelberg Pharma
Freshfields and Greenberg Traurig advised Huadong on the deal. GÖRG Partnerschaft von Rechtsanwälten advised Heidelberg Pharma AG. RITTERSHAUS advised dievini. Huadong Medicine Co Ltd, based in...
Huadong’s Strategic Partnership With Heidelberg Pharma
IN BRIEF: Freshfields Bruckhaus Deringer LLP, advised on the matter. Freshfields Bruckhaus Deringer LLP advised Huadong Medicine Co Ltd with a team including Jan Brinkmann (Tax...